A quality-of-life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire: a prospective comparison of multiple daily insulin injections and continuous subcutaneous insulin infusion

References 

1. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977–986.
2. Namba M. Problem and prospect in CSII. Diab. Front. 2002;13:301–311 in Japanese
3. Kotsanos JG, Vignati L, Huster W, et al.  Health-related quality-of-life results from multinational clinical trials of insulin lispro: assessing benefits of a new diabetes therapy. Diab. Care. 1997;20:948–958
4. Campbell RK, Scla DA, Robinson LM, et al.  Impact on clinical status and quality of life of switching from regular insulin to insulin lispro among patients using insulin pumps. Diab. Educ. 1998;24:95–99
5. Johansson UB, Adamson UC, Lins PE, Wredling RA. Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII: The Swedish Multicenter Lispro Insulin Study. Diab. Metab. 2000;26:192–196
6. Tsui E, Barnie A, Ross S, Parkes R, Zinman B. Intensive insulin therapy with insulin lispro—a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diab. Care. 2001;24:1722–1727
7. Ishii H, Yamamoto T, Ohashi Y. Development of insulin therapy related quality-of-life measure (ITR-QOL). J. Japan Diab. Soc. 2001;44:9–15 in Japanese
8. Ishii H, Yamamoto T, Ohashi Y. Quality of life in insulin users measured by ITR-QOL. J. Japan Diab. Soc. 2001;44:17–22 in Japanese
9. Kamoi K, Sasaki H, Kobayashi T. Effect on glycemic control of short-acting acidified insulin for administered for three years in patients treated by continuous subcutaneous insulin infusion. J. Japan Diab. 2000;Soc.43:847–852 in Japanese
10. The DCCT Research Group, Reliability and validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT), Diab. Care 11 (1988) 725–732.
11. The DCCT Research Group, Influence of intensive diabetes treatment on quality-of-life outcomes in The Diabetes Control and Complications Trial, Diab. Care 19 (1996) 195–203.
12. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diab. Care. 1994;17:267–274
13. Chantelau E, Schiffers T, Schutze J, Hansen B. Effect of patient-selected intensive insulin therapy on quality of life. Patient Educ. Couns. 1977;30:167–173
    • Abstract
    • Full-Text PDF (626 KB)
    • CrossRef
14. Bruttomesso D, Pianta A, Crazzolara D, et al.  Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy. Diab. Med. 2002;19:628–634
15. Schiffers T. Quality of life with intensive insulin therapy: a prospective comparison of insulin pen and pump. Psychother. Psychosom. Med. Psychol. 1977;47:249–254
    • MEDLINE